No expression of human leukocyte antigen G (HLA-G) in colorectal cancer cells

Kawin Leelawat1, Surang Engprasert, Urai Pongchai-rerk

  • 1Department of Anatomy, Faculty of Science, Mahidol University, Thailand. kawin@tubtim.cri.or.th

Insights

Human Leukocyte Antigen-G (HLA-G) expression was investigated in colorectal cancer. This study found no evidence of HLA-G at the protein or transcription level in any colorectal specimens, suggesting it

Area of Science:

  • Immunology
  • Oncology
  • Molecular Biology

Background:

  • Colorectal cancer (CRC) progresses despite the body's antitumor immune response.
  • Cancer cells employ immune evasion mechanisms to escape immune surveillance.
  • Human Leukocyte Antigen-G (HLA-G) is known to inhibit Natural Killer (NK) cell recognition in various cancers.

Purpose of the Study:

  • To investigate the expression of HLA-G in colorectal cancer tissues.
  • To determine if HLA-G is involved in immune evasion in colorectal cancer.

Main Methods:

  • Immunohistochemistry and Reverse Transcription Polymerase Chain Reaction (RT-PCR) were used.
  • Eighty-five specimens including colorectal cancer, carcinoma in situ, and adenomatous polyps were analyzed.
  • Detection of human leukocyte antigen (HLA)-G at both protein and transcription levels.

Main Results:

  • HLA-G expression was not detected in any of the 85 colorectal specimens examined.
  • Absence of HLA-G was confirmed at both the protein and transcriptional levels.
  • No correlation between HLA-G expression and colorectal cancer, carcinoma in situ, or adenomatous polyps was observed.

Conclusions:

  • The expression of HLA-G is not a significant immune evasion mechanism in colorectal cancer.
  • These findings suggest that other pathways are responsible for immune escape in colorectal cancer.
  • Further research is needed to elucidate alternative immune evasion strategies employed by colorectal cancer cells.

Related Concept Videos